WO2026018203 - AMINOISOQUINOLINE COMPOUNDS AND METHODS OF USING THEREOF
National phase entry is expected:
Publication Number
WO/2026/018203
Publication Date
22.01.2026
International Application No.
PCT/IB2025/057266
International Filing Date
17.07.2025
Title **
[English]
AMINOISOQUINOLINE COMPOUNDS AND METHODS OF USING THEREOF
[French]
COMPOSÉS D'AMINOISOQUINOLÉINE ET LEURS PROCÉDÉS D'UTILISATION
Applicants **
NOVARTIS AG
Inventors
BLAQUIERE, Nicole Alice
HOLDER, Lauren
KIRRANE, JR, Thomas Martin
MATA, Anne-Catherine
SARKO, Christopher Ronald
YOKOKAWA, Fumiaki
Priority Data
63/673,363
19.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2914 | |
| EPO | Filing, Examination, Granting | 15635 | |
| Japan | Filing, Examination, Granting | 2481 | |
| South Korea | Filing, Examination, Granting | 2669 | |
| USA | Filing, Examination, Granting | 6790 |
Total:
30,489
Contact Us
Abstract[English]
The present invention relates to a compound of Formula (I), or pharmaceutically acceptable salt thereof, wherein the variables are as defined herein. The invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating plasmodium related diseases such as malaria.[French]
La présente invention concerne un composé de formule (I), ou un sel pharmaceutiquement acceptable de celui-ci, les variables étant telles que définies dans la description. L'invention concerne en outre des compositions pharmaceutiques comprenant de tels composés et des procédés d'utilisation de tels composés pour le traitement de maladies liées à plasmodium telles que le paludisme.